F1CHAPTER 2MARKETING AUTHORISATION REQUIREMENTS

Annotations:
Amendments (Textual)
F1

Regulation revoked (in so far as it applies to medicinal products for human use) (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 9 para. 1(o) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)

F1Article 4Clinical trials

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .